Active ingredientAxitinibCat. No. P-A226-001CAS 319460-85-0Family · Pharmaceutical analytical standards
Axitinib
An inhibitor of VEGF receptors, the signals that drive the growth of new blood vessels in tumours; approved in 2012 in the United States and Europe for advanced renal cell carcinoma. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?In 2015 researchers in Helsinki, testing leukaemia patients' cells against a wide panel of drugs, found that it also blocks a BCR-ABL1 mutation resistant to other treatments.
Go to the active ingredient →Active ingredientAxitinibCat. No. P-A226-001CAS 319460-85-0
MetaboliteAxitinib N-GlucuronideCat. No. P-A226-002
Isotopically labelledAxitinib-13C-d3Cat. No. P-A226-003CAS 1261432-00-1
NitrosamineN-Nitroso AxitinibCat. No. P-A226-004
NitrosamineN-Nitroso-N-Methyl AxitinibCat. No. P-A226-005![2-[(1H-Indazol-6-yl)thio]-N-methylbenzamide](https://img.vitasanlabs.com/vsl-struct/P-A226-006.svg?v=41e934f030)
Impurity2-[(1H-Indazol-6-yl)thio]-N-methylbenzamideCat. No. P-A226-006CAS 944835-85-2![2-[(3-Iodo-1H-indazol-6-yl)thio]-N-methylbenzamide](https://img.vitasanlabs.com/vsl-struct/P-A226-007.svg?v=41e934f030)
Impurity2-[(3-Iodo-1H-indazol-6-yl)thio]-N-methylbenzamideCat. No. P-A226-007CAS 885126-34-1
Impurity2-(1H-Indazol-6-ylsulfinyl)-N-methylbenzamideCat. No. P-A226-008CAS 1959572-97-4![2-[(1-Acetyl-1H-indazol-6-yl)sulfinyl]-N-methylbenzamide](https://img.vitasanlabs.com/vsl-struct/P-A226-009.svg?v=41e934f030)
Impurity2-[(1-Acetyl-1H-indazol-6-yl)sulfinyl]-N-methylbenzamideCat. No. P-A226-009CAS 1959572-98-5
Impurity2-Methyl-1,2-benzisothiazolin-3-oneCat. No. P-A226-010CAS 2527-66-4
Impurity3,6-Diiodo-2H-indazoleCat. No. P-A226-011CAS 319472-78-1
ImpurityAxitinib Impurity 1Cat. No. P-A226-012CAS 886230-77-9
ImpurityAxitinib Des Iodo analogCat. No. P-A226-013CAS 2242852-05-5
ImpurityN-(Tetrahydropyran-2-yl) AxitinibCat. No. P-A226-014CAS 885126-35-2
ImpurityAxitinib DimerCat. No. P-A226-015CAS 1428728-84-0
ImpurityAxitinib Impurity 2Cat. No. P-A226-016CAS 885126-40-9
ImpurityAxitinib Impurity 3Cat. No. P-A226-017
ImpurityAxitinib Impurity 4Cat. No. P-A226-018
ImpurityAxitinib Impurity 5Cat. No. P-A226-019
ImpurityAxitinib Impurity 6Cat. No. P-A226-020
ImpurityAxitinib Impurity 7Cat. No. P-A226-021CAS 1428728-83-9
ImpurityAxitinib Impurity 8Cat. No. P-A226-022
ImpurityAxitinib Impurity 10Cat. No. P-A226-024
ImpurityAxitinib Impurity 11Cat. No. P-A226-025
ImpurityAxitinib Impurity 12Cat. No. P-A226-026
ImpurityAxitinib Impurity 13Cat. No. P-A226-027
ImpurityAxitinib Impurity 14Cat. No. P-A226-028
ImpurityAxitinib Impurity 15Cat. No. P-A226-029
ImpurityAxitinib Impurity 16Cat. No. P-A226-030
ImpurityAxitinib Impurity 17Cat. No. P-A226-031
ImpurityAxitinib Impurity 18Cat. No. P-A226-032
ImpurityAxitinib Impurity 19Cat. No. P-A226-033
ImpurityAxitinib Impurity 20Cat. No. P-A226-034
ImpurityAxitinib Impurity 21Cat. No. P-A226-035
ImpurityAxitinib Impurity 22Cat. No. P-A226-036CAS 1443118-72-6
ImpurityAxitinib lactoseCat. No. P-A226-037
ImpurityAxitinib SulfoneCat. No. P-A226-039CAS 1348536-59-3
ImpurityAxitinib Sulfone N-OxideCat. No. P-A226-040
ImpurityAxitinib Sulfone N-Oxide N-hydroxyCat. No. P-A226-041
ImpurityAxitinib SulfoxideCat. No. P-A226-042CAS 1347304-18-0
ImpurityAxitinib Thiol ImpurityCat. No. P-A226-044CAS 20054-45-9
ImpurityDihydro-AxitinibCat. No. P-A226-045CAS 1443118-73-7
ImpurityN-Acetyl AxitinibCat. No. P-A226-046CAS 1639137-80-6
ImpurityN-Formyl AxitinibCat. No. P-A226-047
ImpurityN-Hydroxy AxitinibCat. No. P-A226-048
ImpurityN-Hydroxymethyl AxitinibCat. No. P-A226-049
ImpurityN-Methyl AxitinibCat. No. P-A226-050No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.